Targeting the sources of chronic inflammatory diseases.

Delivering transformative medicines by advancing and harnessing AI for drug discovery and development

Regenerative medicines for chronic diseases

Advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies

Precision Neuroscience. Transformational therapies

Doppler Bio is developing a next-generation programmable RNA platform with the potential to transform genetic medicine.

Developing therapeutics to eliminate disease-driving cells

Delivering the next generation gene therapies

Unleashing the power of the innate immune system

Expanding the therapeutic potential of gene therapy

Enhanced pairing. Unlocking potential.

Rectifying function, restoring hope. Developing disease-modifying precision therapeutics for patients with serious genetic diseases.

Forging a breakthrough platform for in vivo cell and gene therapy

Focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.

The human approach to oncology

Developing cancer immunotherapeutics based on new insights into the tumor microenvironment

Antibody therapeutics addressing serious unmet medical needs

Developing transformative immuno-stimulatory medicines to unleash a powerful attack on cancer

Developing novel T cell therapeutics in cancer

Addressing the bottlenecks associated with next generation sequencing in translational research by offering a robust platform for targeted sequencing applications

Manipulating metabolism to develop disease modifying therapeutics for immuno-oncology and immuno-inflammation

Developing a new class of medicines to treat cancer & other debilitating diseases

Seeking to detect cancer early, when it can be cured

Developing the leading range of first-in-class inhaled anti-infectives for targeted treatment of life-threatening lung infections

Harnessing the link between the human gut microbiome and the central nervous system to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.

Easing the burden of patients with severe endocrine disorders

Bringing innovation to the delivery of women’s healthcare

Creating a new generation of small molecule protease inhibitors

The leading dermatologist-recommended skin health cosmetics company

Developing oncology therapeutics that inhibit pathways critical to tumor growth and survival

Discovering and developing therapeutics that enhance mitochondrial functions

Minimally invasive solutions for the treatment of bone fractures

Developing therapies to improve the lives of patients diagnosed with cancer in ways that are truly meaningful

Focused on the discovery, development, and commercialization of proprietary small-molecule drugs

Improving nutritional status and pill burden in patients with pancreatic diseases